Microbot Medical Stock Price To Sales
| MBOT Stock | USD 0.98 0.05 5.38% |
Microbot Medical fundamentals help investors to digest information that contributes to Microbot Medical's financial success or failures. It also enables traders to predict the movement of Microbot Stock. The fundamental analysis module provides a way to measure Microbot Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Microbot Medical stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 383.31 | 302.36 |
Microbot | Price To Sales |
Microbot Medical Company Price To Sales Analysis
Microbot Medical's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Microbot Medical Price To Sales | 302.36 |
Most of Microbot Medical's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Microbot Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Microbot Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Microbot Medical is extremely important. It helps to project a fair market value of Microbot Stock properly, considering its historical fundamentals such as Price To Sales. Since Microbot Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Microbot Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Microbot Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Microbot Price To Sales Historical Pattern
Today, most investors in Microbot Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Microbot Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Microbot Medical price to sales as a starting point in their analysis.
Microbot Medical Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Microbot Price To Sales Ratio
Price To Sales Ratio |
|
Microbot Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbot Medical's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbot Medical could also be used in its relative valuation, which is a method of valuing Microbot Medical by comparing valuation metrics of similar companies.Microbot Medical is currently under evaluation in price to sales category among its peers.
Microbot Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Microbot Medical from analyzing Microbot Medical's financial statements. These drivers represent accounts that assess Microbot Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Microbot Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 43.4M | 49.0M | 53.3M | 21.9M | 16.7M | 15.9M | |
| Enterprise Value | 15.5M | 30.2M | 40.5M | 19.9M | 14.5M | 28.5M |
Microbot Fundamentals
| Return On Equity | -1.34 | ||||
| Return On Asset | -0.65 | ||||
| Current Valuation | 12.35 M | ||||
| Shares Outstanding | 16.93 M | ||||
| Shares Owned By Insiders | 1.42 % | ||||
| Shares Owned By Institutions | 7.46 % | ||||
| Number Of Shares Shorted | 565.98 K | ||||
| Price To Earning | (3.42) X | ||||
| Price To Book | 4.36 X | ||||
| EBITDA | (10.63 M) | ||||
| Net Income | (10.74 M) | ||||
| Cash And Equivalents | 9.29 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 231 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 0.38 X | ||||
| Cash Flow From Operations | (8.53 M) | ||||
| Short Ratio | 2.65 X | ||||
| Earnings Per Share | (0.79) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 21 | ||||
| Beta | 1.63 | ||||
| Market Capitalization | 16.59 M | ||||
| Total Asset | 8.33 M | ||||
| Retained Earnings | (79.5 M) | ||||
| Working Capital | 4.13 M | ||||
| Current Asset | 15.21 M | ||||
| Current Liabilities | 9.83 M | ||||
| Net Asset | 8.33 M |
About Microbot Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbot Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbot Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbot Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.